LGND Insider Trading

Insider Ownership Percentage: 5.90%
Insider Buying (Last 12 Months): $237,520.00
Insider Selling (Last 12 Months): $2,303,916.39

Ligand Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Ligand Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ligand Pharmaceuticals Share Price & Price History

Current Price: $99.76
Price Change: Price Increase of +0.8 (0.81%)
As of 07/19/2024 09:55 PM ET

This chart shows the closing price history over time for LGND up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ligand Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/17/2024Octavio EspinozaCFOSell5,156$86.66$446,818.9623,379View SEC Filing Icon  
5/15/2024Octavio EspinozaCFOSell5,873$86.01$505,136.7323,882View SEC Filing Icon  
5/13/2024Matthew E KorenbergInsiderSell3,440$84.54$290,817.60100,421View SEC Filing Icon  
5/9/2024Andrew ReardonInsiderSell10,000$83.04$830,400.0022,205View SEC Filing Icon  
5/9/2024Nancy Ryan GrayDirectorSell934$83.20$77,708.805,633View SEC Filing Icon  
3/5/2024Stephen L SabbaDirectorSell1,893$74.30$140,649.9028,926View SEC Filing Icon  
2/28/2024Octavio EspinozaCFOSell140$88.46$12,384.4029,755View SEC Filing Icon  
9/22/2023Todd C DavisCEOBuy4,000$59.38$237,520.0073,090View SEC Filing Icon  
5/16/2023John W KozarichDirectorSell4,444$77.20$343,076.8038,488View SEC Filing Icon  
5/10/2023Stephen L SabbaDirectorSell6,408$77.13$494,249.0425,784View SEC Filing Icon  
5/8/2023John W KozarichDirectorSell6,408$76.56$490,596.4842,213View SEC Filing Icon  
3/24/2023Andrew ReardonInsiderSell300$69.92$20,976.0016,308View SEC Filing Icon  
12/16/2022John L. HigginsDirectorSell10,000$61.87$618,700.00422,984View SEC Filing Icon  
11/17/2022John L. HigginsCEOSell10,000$78.32$783,200.00416,731View SEC Filing Icon  
11/9/2022Octavio EspinozaCFOSell1,696$75.64$128,285.448,857View SEC Filing Icon  
9/15/2022John L. HigginsCEOSell2,000$90.00$180,000.00367,180View SEC Filing Icon  
5/13/2022Matthew W. FoehrCOOBuy2,500$82.76$206,900.00173,354View SEC Filing Icon  
2/28/2022John W KozarichDirectorSell908$102.62$93,178.96View SEC Filing Icon  
11/12/2021John L. HigginsCEOSell3,000$160.50$481,500.00View SEC Filing Icon  
11/11/2021Matthew W. FoehrCOOSell11,160$163.02$1,819,303.20View SEC Filing Icon  
8/4/2021Matthew W. FoehrCOOSell8,840$109.67$969,482.80173,195View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ligand Pharmaceuticals (NASDAQ:LGND)

91.28% of Ligand Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LGND by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ligand Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/19/2024BTC Capital Management Inc.4,269$0.36M0.0%-7.3%0.024%Search for SEC Filing on Google Icon
7/18/2024Portside Wealth Group LLC2,722$0.23M0.0%N/A0.015%Search for SEC Filing on Google Icon
7/16/2024Sequoia Financial Advisors LLC4,029$0.34M0.0%N/A0.022%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC6,624$0.56M0.0%-40.1%0.037%Search for SEC Filing on Google Icon
7/10/2024Linden Thomas Advisory Services LLC17,112$1.44M0.2%+1.6%0.095%Search for SEC Filing on Google Icon
7/8/2024Woodstock Corp29,111$2.45M0.2%-3.3%0.162%Search for SEC Filing on Google Icon
5/22/2024Burney Co.3,524$0.26M0.0%+13.4%0.020%Search for SEC Filing on Google Icon
5/17/2024Comerica Bank7,842$0.57M0.0%-8.6%0.044%Search for SEC Filing on Google Icon
5/17/2024Castleark Management LLC61,913$4.53M0.2%-1.3%0.344%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System16,594$1.21M0.0%-5.3%0.092%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.14,762$1.08M0.0%-27.2%0.082%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC1,008,477$73.72M0.0%-24.9%5.603%Search for SEC Filing on Google Icon
5/16/2024Ashford Capital Management Inc.196,535$14.37M1.9%N/A1.092%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD12,992$0.95M0.0%+4.9%0.072%Search for SEC Filing on Google Icon
5/14/2024CANADA LIFE ASSURANCE Co21,701$1.58M0.0%+5.0%0.121%Search for SEC Filing on Google Icon
5/11/2024Hillsdale Investment Management Inc.45,032$3.29M0.3%+8.4%0.254%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,884,112$137.73M0.0%+0.4%10.642%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System4,070$0.30M0.0%-14.5%0.023%Search for SEC Filing on Google Icon
5/8/2024Everence Capital Management Inc.2,760$0.20M0.0%N/A0.016%Search for SEC Filing on Google Icon
5/8/2024William Blair Investment Management LLC189,247$13.83M0.0%+1.0%1.069%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC4,627$0.34M0.0%+8.5%0.026%Search for SEC Filing on Google Icon
5/8/2024Isthmus Partners LLC48,331$3.53M0.4%+40.7%0.273%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.73,161$5.35M0.0%+155.3%0.413%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC623$46K0.0%-35.4%0.004%Search for SEC Filing on Google Icon
5/7/2024Sei Investments Co.35,841$2.62M0.0%+224.1%0.202%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank32,700$2.39M0.0%+0.6%0.185%Search for SEC Filing on Google Icon
5/7/2024Illinois Municipal Retirement Fund10,158$0.74M0.0%+8.4%0.057%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC11,061$0.81M0.0%N/A0.062%Search for SEC Filing on Google Icon
5/6/2024Texas Permanent School Fund Corp14,344$1.05M0.0%+1.3%0.081%Search for SEC Filing on Google Icon
5/2/2024Nordea Investment Management AB68,328$4.94M0.0%-0.9%0.386%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets9,296$0.68M0.0%-49.7%0.053%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.92,124$6.73M0.0%-0.7%0.520%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.3,437$0.25M0.0%+70.8%0.019%Search for SEC Filing on Google Icon
4/26/2024Yousif Capital Management LLC7,446$0.54M0.0%-9.1%0.042%Search for SEC Filing on Google Icon
4/25/2024Villere ST Denis J & Co. LLC490,752$35.87M2.9%+14.6%2.773%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC279,784$20.45M1.2%+1.4%1.581%Search for SEC Filing on Google Icon
4/23/2024KLR Investment Advisors LLC4,497$0.31M0.2%N/A0.025%Search for SEC Filing on Google Icon
4/19/2024AMI Asset Management Corp40,931$2.99M0.2%-4.0%0.231%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC85,195$6.23M0.0%+129.2%0.481%Search for SEC Filing on Google Icon
4/11/2024BTC Capital Management Inc.4,605$0.34M0.0%N/A0.026%Search for SEC Filing on Google Icon
4/2/2024M&R Capital Management Inc.2,000$0.15M0.0%N/A0.011%Search for SEC Filing on Google Icon
3/22/2024PNC Financial Services Group Inc.1,840$0.13M0.0%+32.4%0.010%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.1,876,514$134.02M0.0%+1.3%10.602%Search for SEC Filing on Google Icon
3/5/2024Fisher Asset Management LLC49,297$3.52M0.0%+48.2%0.279%Search for SEC Filing on Google Icon
2/22/2024Scarborough Advisors LLC1,502$0.11M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/16/2024Spouting Rock Asset Management LLC3,445$0.25M0.1%-62.6%0.020%Search for SEC Filing on Google Icon
2/13/2024Stephens Investment Management Group LLC659,434$47.10M0.7%+41.0%3.801%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC7,581$0.54M0.0%+47.3%0.044%Search for SEC Filing on Google Icon
2/12/2024Isthmus Partners LLC34,347$2.45M0.3%+4.7%0.198%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.14,066$1.01M0.0%+3.2%0.081%Search for SEC Filing on Google Icon
2/9/2024GW&K Investment Management LLC55,335$3.95M0.0%+47.8%0.319%Search for SEC Filing on Google Icon
2/9/2024Hillsdale Investment Management Inc.41,532$2.97M0.2%-12.8%0.239%Search for SEC Filing on Google Icon
2/9/2024Norges Bank107,188$7.66M0.0%N/A0.618%Search for SEC Filing on Google Icon
2/8/2024Brown Advisory Inc.7,757$0.55M0.0%N/A0.045%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.92,810$6.63M0.0%-1.3%0.535%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP661,298$47.23M0.0%+7.6%3.812%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets18,482$1.32M0.0%-11.1%0.107%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas3,814$0.27M0.0%-18.0%0.022%Search for SEC Filing on Google Icon
2/7/2024Versor Investments LP3,848$0.28M0.1%-23.8%0.022%Search for SEC Filing on Google Icon
2/7/2024Principal Securities Inc.747$53K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.161,480$11.53M0.0%+2.7%0.931%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank6,294$0.45M0.0%-2.4%0.036%Search for SEC Filing on Google Icon
2/6/2024Summit Global Investments19,397$1.39M0.1%-12.2%0.112%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank32,500$2.32M0.0%-10.0%0.187%Search for SEC Filing on Google Icon
2/6/2024Fisher Asset Management LLC49,297$3.52M0.0%+48.2%0.284%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.21,385$1.53M0.0%+22.8%0.123%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.28,662$2.05M0.0%+65.5%0.165%Search for SEC Filing on Google Icon
2/2/2024Headlands Technologies LLC964$69K0.0%-29.8%0.006%Search for SEC Filing on Google Icon
2/2/2024Cornerstone Capital Inc.6,957$0.50M0.1%-7.3%0.040%Search for SEC Filing on Google Icon
2/2/2024Acuitas Investments LLC47,703$3.41M1.7%N/A0.275%Search for SEC Filing on Google Icon
2/1/2024Linden Thomas Advisory Services LLC16,393$1.17M0.2%-2.3%0.094%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund7,200$0.51M0.0%-7.4%0.041%Search for SEC Filing on Google Icon
2/1/2024Illinois Municipal Retirement Fund9,368$0.67M0.0%-2.0%0.054%Search for SEC Filing on Google Icon
2/1/2024Cetera Trust Company N.A2,205$0.16M0.1%N/A0.013%Search for SEC Filing on Google Icon
1/31/2024abrdn plc290,418$20.74M0.0%-9.3%1.674%Search for SEC Filing on Google Icon
1/31/2024Calamos Advisors LLC4,586$0.33M0.0%N/A0.026%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.38,964$2.78M0.0%-20.5%0.225%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio11,000$0.79M0.0%-2.7%0.063%Search for SEC Filing on Google Icon
1/29/2024Louisiana State Employees Retirement System8,200$0.59M0.0%N/A0.047%Search for SEC Filing on Google Icon
1/29/2024Smith Graham & Co. Investment Advisors LP83,121$5.94M0.7%+34.4%0.479%Search for SEC Filing on Google Icon
1/26/2024Mutual of America Capital Management LLC2,869$0.21M0.0%N/A0.017%Search for SEC Filing on Google Icon
1/26/2024Impax Asset Management Group plc205,208$14.66M0.1%+11.3%1.183%Search for SEC Filing on Google Icon
1/25/2024Allspring Global Investments Holdings LLC37,173$2.66M0.0%+98.8%0.214%Search for SEC Filing on Google Icon
1/25/2024International Assets Investment Management LLC5,785$0.41M0.0%N/A0.033%Search for SEC Filing on Google Icon
1/25/2024Villere ST Denis J & Co. LLC428,051$30.57M2.5%-2.3%2.467%Search for SEC Filing on Google Icon
1/24/2024International Assets Investment Management LLC5,785$0.41M0.0%N/A0.033%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.2,012$0.14M0.0%+356.2%0.012%Search for SEC Filing on Google Icon
1/22/2024Chicago Capital LLC231,511$16.54M0.6%-35.8%1.334%Search for SEC Filing on Google Icon
1/19/2024AMI Asset Management Corp42,619$3.04M0.2%+25.6%0.246%Search for SEC Filing on Google Icon
1/16/2024Pacer Advisors Inc.325,727$23.26M0.1%+59.1%1.877%Search for SEC Filing on Google Icon
1/16/2024Legato Capital Management LLC2,975$0.21M0.0%N/A0.017%Search for SEC Filing on Google Icon
1/12/2024Advisor Resource Council2,804$0.20M0.0%N/A0.016%Search for SEC Filing on Google Icon
1/11/2024Ziegler Capital Management LLC50,423$3.60M0.2%-59.1%0.291%Search for SEC Filing on Google Icon
1/10/2024Nordea Investment Management AB68,971$4.93M0.0%-3.3%0.398%Search for SEC Filing on Google Icon
1/8/2024Woodstock Corp30,111$2.15M0.2%-11.9%0.174%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.1,851,861$110.96M0.0%-0.1%10.670%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.8,777$0.53M0.0%-45.4%0.051%Search for SEC Filing on Google Icon
11/24/2023Deutsche Bank AG136,229$8.16M0.0%+43.0%0.785%Search for SEC Filing on Google Icon
11/15/2023Kennedy Capital Management LLC35,699$2.14M0.1%+3.5%0.206%Search for SEC Filing on Google Icon
11/14/2023Gotham Asset Management LLC7,483$0.45M0.0%-19.4%0.043%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ligand Pharmaceuticals logo
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Filspari, a dual endothelin and angiotensin II receptor antagonist in development for rare kidney diseases and non-immunosuppressive treatment indicated for immunoglobulin A nephropathy; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by streptococcus pneumoniae serotypes; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression; and Veklury, an antiviral treatment for moderate or severe COVID-19. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of post-menopausal symptoms in women; Exemptia for autoimmune diseases; Vivitra for breast cancer; and Bryxta and Zybev for various indications. The company has alliances, licenses, and other business relationships with Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Further, it sells Captisol materials. Ligand Pharmaceuticals Incorporated was incorporated in 1987 and is based in Jupiter, Florida.
Read More on Ligand Pharmaceuticals

Today's Range

Now: $99.76
Low: $98.33
High: $101.70

50 Day Range

MA: $85.87
Low: $77.82
High: $101.07

52 Week Range

Now: $99.76
Low: $49.24
High: $101.92

Volume

82,200 shs

Average Volume

151,021 shs

Market Capitalization

$1.80 billion

P/E Ratio

19.30

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Ligand Pharmaceuticals?

Ligand Pharmaceuticals' top insider investors include:
  1. John L Higgins (Director)
  2. John L Higgins (CEO)
  3. Matthew E Korenberg (Insider)
  4. Todd C Davis (CEO)
  5. John W Kozarich (Director)
  6. Octavio Espinoza (CFO)
  7. Stephen L Sabba (Director)
  8. Andrew Reardon (Insider)
  9. Nancy Ryan Gray (Director)
Learn More about top insider investors at Ligand Pharmaceuticals.

Who are the major institutional investors of Ligand Pharmaceuticals?

Ligand Pharmaceuticals' top institutional investors include:
  1. Woodstock Corp — 0.16%
  2. Linden Thomas Advisory Services LLC — 0.10%
  3. SG Americas Securities LLC — 0.04%
  4. BTC Capital Management Inc. — 0.02%
  5. Sequoia Financial Advisors LLC — 0.02%
  6. Portside Wealth Group LLC — 0.02%
Learn More about top institutional investors of Ligand Pharmaceuticals stock.

Which institutional investors are selling Ligand Pharmaceuticals stock?

In the previous quarter, LGND stock was sold by these institutional investors:
  1. SG Americas Securities LLC
  2. Woodstock Corp
  3. BTC Capital Management Inc.
During the previous year, company insiders that have sold Ligand Pharmaceuticals company stock include:
  1. John L Higgins (Director)
  2. John L Higgins (CEO)
  3. Matthew E Korenberg (Insider)
  4. Todd C Davis (CEO)
  5. John W Kozarich (Director)
Learn More investors selling Ligand Pharmaceuticals stock.

Which institutional investors are buying Ligand Pharmaceuticals stock?

During the previous quarter, LGND stock was acquired by institutional investors including:
  1. Sequoia Financial Advisors LLC
  2. Portside Wealth Group LLC
  3. Linden Thomas Advisory Services LLC